Related Experiment Video
Updated: Jun 5, 2026
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
Clinical and biological significance of nemo-like kinase expression in glioma
1Department of Neurosurgery, First Affiliated Hospital of Soochow University, Suzhou, China.
Abstract:
Nemo-like kinase (NLK) is an evolutionarily conserved serine/threonine kinase that suppresses the transcriptional activity of β-catenin/T-cell factor complex through phosphorylation of T-cell factor. Wnt/β-catenin signaling is thought to play a critical role in human carcinogenesis, so it is possible that NLK acts as a tumor suppressor by regulating the Wnt/β-catenin pathway. In the present study we investigated NLK expression in human gliomas in order to better understand its potential value as a therapeutic target for this disease. Specimens from 70 human gliomas were subjected to immunohistochemical and western blot analysis. We found that NLK expression was directly but inversely correlated with glioma grade. A low NLK expression level was associated with poor patient outcome. We also analyzed the effect of overexpression of NLK on cell apoptosis using a cell counting kit and western blot analysis. Our results suggest that NLK induces apoptosis in glioma cells via activation of caspases. NLK may be a useful independent prognostic indicator for glioma. Gene therapeutic approaches aimed at upregulating NLK expression could be developed for treatment of glioma.
Insights
Nemo-like kinase (NLK) suppresses glioma progression. Lower NLK expression correlates with higher glioma grade and poorer outcomes, suggesting NLK as a potential therapeutic target for glioma treatment.
Area of Science:
- Oncology
- Molecular Biology
- Neuroscience
Background:
- Nemo-like kinase (NLK) is a serine/threonine kinase regulating beta-catenin/T-cell factor transcriptional activity.
- Wnt/beta-catenin signaling is implicated in human carcinogenesis, suggesting NLK's potential tumor suppressor role.
Purpose of the Study:
- To investigate NLK expression in human gliomas.
- To assess NLK's correlation with glioma grade and patient prognosis.
- To elucidate NLK's role in glioma cell apoptosis.
Main Methods:
- Immunohistochemistry and Western blot analysis of 70 human glioma specimens.
- Overexpression of NLK in glioma cells.
- Cell counting kit assay and Western blot analysis to assess apoptosis and caspase activation.
Main Results:
- NLK expression inversely correlated with glioma grade.
- Low NLK expression was associated with poor patient outcomes.
- NLK overexpression induced glioma cell apoptosis via caspase activation.
Conclusions:
- NLK functions as a tumor suppressor in human gliomas.
- NLK is a potential independent prognostic indicator for glioma.
- Upregulating NLK expression may offer a gene therapeutic strategy for glioma treatment.